Arcline Investment Management Acquires Controlling Stake in Resolution Medical
June 2, 2021
Arcline Investment Management acquired a controlling stake in Resolution Medical from founders Steve Schmidt and Shawn Patterson, with Culper Capital Partners joining as a minority investor. Resolution Medical, a Minneapolis-based medical device CDMO specializing in complex interventional therapies, will retain its senior leadership while Luke Johnson joins as Executive Chairman as Arcline seeks to build a leading CDMO platform.
- Buyers
- Arcline Investment Management, Culper Capital Partners
- Targets
- Resolution Medical, LLC
- Sellers
- Steve Schmidt, Shawn Patterson
- Industry
- Medical Devices
- Location
- Minnesota, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Arcline Investment Management Acquires SYNEO
October 28, 2020
Medical Devices
Arcline Investment Management, a growth-oriented private equity firm, acquired a controlling stake in SYNEO from Rockwood Equity Partners. SYNEO is a vertically-integrated machine, tooling and services company serving the interventional medical device and specialty press-fit PCB markets, with manufacturing facilities in West Palm Beach, Florida and Angleton, Texas and forward-deployed sales/service offices in Europe and Asia.
-
Arcline Investment Management Acquires Integrated Medical Holdings
November 4, 2020
Medical Devices
Arcline Investment Management acquired a controlling stake in Integrated Medical Holdings (IMH) from founder Bob Winters. IMH provides catheter tipping and hole-punching equipment as well as vertically integrated catheter contract manufacturing services and will join Arcline’s medical-oriented manufacturing equipment platform alongside Glebar, SYNEO and Everite Machine Products.
-
Arcline Investment Management Acquires Majority Interest in Akron Biotechnology
September 11, 2019
Biotechnology
Arcline Investment Management has acquired a majority interest in Akron Biotechnology LLC, a supplier of cGMP-compliant materials and services for cell and gene therapy manufacturers. Akron will remain led by founder and CEO Dr. Claudia Zylberberg, and Arcline plans to expand Akron's manufacturing capacity and pursue complementary acquisitions to build a platform in regenerative medicine.
-
Arcline Investment Management Acquires Engineering by Design
December 16, 2020
Medical Devices
Arcline Investment Management, a growth-oriented private equity firm, has acquired a controlling stake in Engineering by Design (EBD) from founders Dale and Judy Henson. EBD will join Arcline's medical-oriented manufacturing equipment platform (including Glebar, Everite Machine Products, SYNEO and Cath-Tip), expanding Arcline's capabilities in precision equipment and consumables for interventional medical device manufacturing.
-
Arcline Investment Management Makes Strategic Investment in American Casting Company
December 2, 2025
Aerospace & Defense
Arcline Investment Management, a growth-oriented private equity firm, completed a strategic investment in American Casting Company (ACC), a Hollister, California-based provider of engineered investment castings for aerospace, defense, medical and energy applications. ACC will continue to be led by CEO Chris St. John; Arcline plans to support expansion of the company’s capabilities and capacity to meet rising demand from OEMs reshoring mission‑critical components. Janes Capital Partners served as financial advisor to the company.
-
Arcline Investment Management Acquires Controlling Stake in Air Comm Corporation
July 6, 2021
Aerospace & Defense
Arcline Investment Management acquired a controlling stake in Air Comm Corporation in a transaction valuing the company at $250 million; Dave Harrison remains a significant minority shareholder and will serve as Chairman. Air Comm, based in Westminster, Colorado, designs, manufactures, and services environmental control and thermal management systems for aerospace OEMs, fleets and aftermarket service providers; Arcline plans to partner with management to expand MRO capabilities and pursue organic and inorganic growth.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.